14-23321490-G-GGCA
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM1PP5
The ENST00000216727.9(PABPN1):c.30_32dup(p.Ala10dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000478 in 1,198,220 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00050 ( 0 hom. )
Consequence
PABPN1
ENST00000216727.9 inframe_insertion
ENST00000216727.9 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.57
Genes affected
PABPN1 (HGNC:8565): (poly(A) binding protein nuclear 1) This gene encodes an abundant nuclear protein that binds with high affinity to nascent poly(A) tails. The protein is required for progressive and efficient polymerization of poly(A) tails at the 3' ends of eukaryotic transcripts and controls the size of the poly(A) tail to about 250 nt. At steady-state, this protein is localized in the nucleus whereas a different poly(A) binding protein is localized in the cytoplasm. This gene contains a GCG trinucleotide repeat at the 5' end of the coding region, and expansion of this repeat from the normal 6 copies to 8-13 copies leads to autosomal dominant oculopharyngeal muscular dystrophy (OPMD) disease. Related pseudogenes have been identified on chromosomes 19 and X. Read-through transcription also exists between this gene and the neighboring upstream BCL2-like 2 (BCL2L2) gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM1
In a region_of_interest Disordered (size 114) in uniprot entity PABP2_HUMAN there are 29 pathogenic changes around while only 2 benign (94%) in ENST00000216727.9
PP5
Variant 14-23321490-G-GGCA is Pathogenic according to our data. Variant chr14-23321490-G-GGCA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1323406.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=1, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PABPN1 | NM_004643.4 | c.30_32dup | p.Ala10dup | inframe_insertion | 1/7 | ENST00000216727.9 | NP_004634.1 | |
BCL2L2-PABPN1 | NM_001387343.1 | c.529-682_529-680dup | intron_variant | NP_001374272.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PABPN1 | ENST00000216727.9 | c.30_32dup | p.Ala10dup | inframe_insertion | 1/7 | 1 | NM_004643.4 | ENSP00000216727 | P1 | |
PABPN1 | ENST00000397276.6 | c.30_32dup | p.Ala10dup | inframe_insertion | 1/6 | 1 | ENSP00000380446 |
Frequencies
GnomAD3 genomes AF: 0.000332 AC: 50AN: 150828Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
50
AN:
150828
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000285 AC: 2AN: 7014Hom.: 0 AF XY: 0.000540 AC XY: 2AN XY: 3706
GnomAD3 exomes
AF:
AC:
2
AN:
7014
Hom.:
AF XY:
AC XY:
2
AN XY:
3706
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000499 AC: 523AN: 1047284Hom.: 0 Cov.: 31 AF XY: 0.000519 AC XY: 258AN XY: 497094
GnomAD4 exome
AF:
AC:
523
AN:
1047284
Hom.:
Cov.:
31
AF XY:
AC XY:
258
AN XY:
497094
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000331 AC: 50AN: 150936Hom.: 0 Cov.: 32 AF XY: 0.000312 AC XY: 23AN XY: 73758
GnomAD4 genome
AF:
AC:
50
AN:
150936
Hom.:
Cov.:
32
AF XY:
AC XY:
23
AN XY:
73758
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
2
AN:
3452
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Oculopharyngeal muscular dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 18, 2024 | - - |
Oculopharyngeal muscular dystrophy 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM4+PS4_Supporting - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at